TRIB
Trinity Biotech plc
NASDAQ: TRIB · HEALTHCARE · MEDICAL DEVICES
$0.60
+0.00% today
Updated 2026-04-30
Market cap
$12.18M
P/E ratio
—
P/S ratio
0.25x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Trinity Biotech plc (TRIB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-75.90%
Operating margin
-3.56%
ROE
-1,913.00%
ROA
-9.46%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $98.56M | $5.28M | 47.87% | 6.72% | 5.36% |
| 2006 | $118.67M | $3.28M | 42.79% | 1.64% | 2.76% |
| 2007 | $143.62M | $-35.37M | 38.47% | -20.45% | -24.63% |
| 2008 | $140.14M | $-77.78M | 44.59% | -56.78% | -55.50% |
| 2009 | $125.91M | $11.82M | 45.28% | 11.20% | 9.39% |
| 2010 | $89.64M | $60.42M | 49.03% | 15.65% | 67.40% |
| 2011 | $77.95M | $15.59M | 51.48% | 20.25% | 20.00% |
| 2012 | $82.51M | $17.34M | 51.21% | 20.80% | 21.02% |
| 2013 | $91.22M | $10.34M | 50.33% | 19.59% | 11.33% |
| 2014 | $104.87M | $17.21M | 48.01% | 17.20% | 16.41% |
| 2015 | $100.19M | $21.80M | 46.15% | 13.42% | 21.75% |
| 2016 | $99.61M | $-100.63M | 43.26% | 7.52% | -101.02% |
| 2017 | $99.14M | $-40.27M | 42.25% | 5.53% | -40.62% |
| 2018 | $97.03M | $2.39M | 42.72% | 3.40% | 2.46% |
| 2019 | $90.44M | $-4.07M | 42.15% | 0.96% | -4.50% |
| 2020 | $101.98M | $-6.39M | 47.64% | 0.08% | -6.26% |
| 2021 | $81.15M | $875000.00 | 41.23% | 4.85% | 1.08% |
| 2022 | $62.52M | $-41.00M | 35.26% | -24.42% | -65.58% |
| 2023 | $56.83M | $-24.02M | 34.22% | -47.59% | -42.26% |
| 2024 | $61.55M | $-31.79M | 34.83% | -34.38% | -51.64% |